News

Stocks

Reuters | Equities.com |

Hundreds of thousands of COVID-19 vaccine doses have been saved from the trash after U.S. regulators extended their expiration date for a second time, part of a nationwide effort to salvage expiring shots to battle the nation’s summer surge in infections.

The Food and Drug Administration on Wednesday sent a letter to shot maker Johnson & Johnson declaring that the doses remain safe and effective for at least six months when properly stored. The FDA’s move gives the shots an extra six weeks as public officials press more Americans to get inoculated.


AP News | Equities.com |

Vaccinations are beginning to rise in some states where COVID-19 cases are soaring, White House officials said Thursday in a sign that the summer surge is getting the attention of vaccine-hesitant Americans as hospitals in the South are being overrun with patients.

Coronavirus coordinator Jeff Zients told reporters that several states with the highest proportions of new infections have seen residents get vaccinated at higher rates than the nation as a whole. Officials cited Arkansas, Florida, Louisiana, Missouri and Nevada as examples.


AP News | Equities.com |

China cannot accept the World Health Organization’s plan for the second phase of a study into the origins of COVID-19, a senior Chinese health official said Thursday.

Zeng Yixin, the vice minister of the National Health Commission, said he was “rather taken aback” that the plan includes further investigation of the theory that the virus might have leaked from a Chinese lab.


Reuters | Equities.com |

A group of state attorneys general unveiled on Wednesday a landmark $26 billion settlement with large drug companies for allegedly fueling the deadly nationwide opioid epidemic, but the deal still requires support from thousands of local governments.

Under the settlement proposal, the three largest U.S. drug distributors — McKesson Corp, Cardinal Health Inc and AmerisourceBergen Corp — are expected to pay a combined $21 billion, while drugmaker Johnson & Johnson would pay $5 billion.


Reuters | Equities.com |

The United States and Germany on Wednesday unveiled an agreement on the Nord Stream 2 gas pipeline under which Berlin pledged to respond to any attempt by Russia to use energy as a weapon against Ukraine and other Central and Eastern European countries.

The pact aims to mitigate what critics see as the strategic dangers of the $11 billion pipeline, now 98% complete, being built under the Baltic Sea to carry gas from Russia's Arctic region to Germany.


AP News | Equities.com |

COVID-19 cases tripled in the U.S. over two weeks amid an onslaught of vaccine misinformation that is straining hospitals, exhausting doctors and pushing clergy into the fray.

“Our staff, they are frustrated,” said Chad Neilsen, director of infection prevention at UF Health Jacksonville, a Florida hospital that is canceling elective surgeries and procedures after the number of mostly unvaccinated COVID-19 inpatients at its two campuses jumped to 134, up from a low of 16 in mid-May.


Kimberly Redmond | Equities.com |

The US Food and Drug Administration (FDA) has agreed to a “priority review” of Pfizer-BioNTech’s COVID-19 vaccine for a full approval decision by January 2022.

According to FDA commissioner Dr. Janet Woodcock, action will likely come much sooner because regulators consider the review “among the highest priorities of the agency.”


Kimberly Redmond | Equities.com |

Former BP plc (NYSE: BP) chief executive officer and soon-to-be-retiring Glencore plc (OTC: GLNCY) chairman Tony Hayward is launching a new special purpose acquisition company (SPAC) focused on clean energy projects in Europe.

According to Sky News, Hayward's Energy Transition Partners seeks to raise 175 million euros ($207 million) with a listing on the Euronext Amsterdam stock exchange.


Reuters | Equities.com |

U.S. COVID-19 cases are up around 11% over the previous week, almost entirely among people who have not been vaccinated, officials said on Thursday, as the highly infectious Delta variant becomes the dominant COVID-19 strain in the country.

Around 93% of COVID-19 cases in recent days have occurred in counties with vaccination rates of less than 40%, U.S. Centers for Disease Control and Prevention director Rochelle Walensky told a media briefing.


Reuters | Equities.com |

Marlboro cigarettes maker Philip Morris International agreed on Friday to buy British drugmaker Vectura for 1.05 billions pounds ($1.44 billion) to bolster its portfolio of products that are free from tobacco or nicotine.

The deal, which topped a proposal by investment firm Carlyle Group, means shareholders in the drugmaker that makes 13 inhaled medicines will get 150 pence per share in cash, 11% higher than its Thursday closing price.